Galectin Therapeutics Inc. (GALT) ownership: Top institutional holder: VANGUARD GROUP INC ($9.52M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| VANGUARD GROUP INC | 2288848.00 | $9.52M | 2025-12-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1966542.00 | $5.49M | 2026-03-31 |
| MARSHALL WACE, LLP | 1219912.00 | $3.40M | 2026-03-31 |
| OSAIC HOLDINGS, INC. | 1122670.00 | $3.13M | 2026-03-31 |
| GREAT POINT PARTNERS LLC | 800000.00 | $2.23M | 2026-03-31 |
| BlackRock, Inc. | 799237.00 | $2.23M | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 798434.00 | $2.23M | 2026-03-31 |
| Wealthspire Advisors, LLC | 721788.00 | $2.01M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-07-31 | |
| Sell | null | 2026-07-31 | |
| Sell | null | 2026-07-31 | |
| Sell | null | 2026-07-31 | |
| Sell | null | 2026-07-14 | |
| Sell | null | 2026-07-14 | |
| Sell | null | 2026-07-14 | |
| Sell | null | 2026-06-26 |
Back to GALT overview · GALT earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.